ABT Debt Analysis
Abbott Laboratories - Total Debt & Leverage Ratios
Data as of 12/31/2025
Debt Health Rating
Excellent
Very low debt levels with strong coverage
Key Debt Metrics
$15.96B
Combined long & short-term
0.31x
Leverage ratio
57.11x
Op. income / interest
Debt Structure
Long-term Debt
Due after 1 year
Short-term Debt
Due within 1 year
Annual Interest Expense
Cost of debt per year
Net Debt
Total debt minus cash
Leverage Ratios
Debt-to-Assets
Total debt / Total assets
Debt Service Coverage
Cash flow / Interest
Debt Activity (Annual)
New Debt Issued
$3.00M
Debt Repaid
$1.50B
Net Change
$-1.50B
Reducing debt
Balance Sheet Context
Cash & Equivalents
$8.52B
Total Assets
$86.71B
Stockholders Equity
$52.13B
Operating Income
$8.05B
Operating Cash Flow
$9.57B
View Detailed Debt Analysis
Explore maturity schedules, corporate bonds, and risk analysis
View Full Debt ReportFrequently Asked Questions
What is ABT total debt?
ABT has total debt of $15.96B, consisting of $12.93B in long-term debt and $3.03B in short-term debt.
What is ABT debt-to-equity ratio?
ABT's debt-to-equity ratio is 0.31x. This indicates conservative leverage.
What is ABT interest coverage ratio?
ABT has an interest coverage ratio of 57.11x, meaning it generates 57.1 times its annual interest expense in operating income. This indicates strong ability to service debt.
Is ABT debt level healthy?
ABT has a debt health rating of "Excellent". Very low debt levels with strong coverage. The company is actively reducing its debt levels.
How much is ABT net debt?
ABT's net debt (total debt minus cash) is $7.44B. This represents the actual debt burden after accounting for cash reserves.